Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515800 · ClinicalTrials.gov registry record · NA
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
A NA study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- NA
- Development phase
- 724
- Enrollment target
NCT01515800 is a NA study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 724 participants.
The verdict
NCT01515800, a NA study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 724 participants
- Enrollment target
Study Summary
RATIONALE: Measuring how text-message affects treatment compliance in women with breast cancer may help doctors plan the best treatment. PURPOSE: This randomized trial studies how well text-message works in reducing early discontinuation of aromatase inhibitor therapy in patients with early-stage breast cancer who underwent breast surgery.
Interventions
- BEHAVIORAL Text message reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 724 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515800
The ClinicalTrials.gov registry entry for NCT01515800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 724 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text message reminder is the first listed.
NCT01515800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01515800 about?
NCT01515800 is a clinical study titled "S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer". RATIONALE: Measuring how text-message affects treatment compliance in women with breast cancer may help doctors plan the best treatment. PURPOSE: This randomized trial studies how well text-message works in reducing early discontinuation of aromatase inhibitor therapy in patients with early-stage b...
What is the current status of trial NCT01515800?
This trial is currently completed. It is a NA study. The enrollment target is 724 participants. The study started on 2012-05. Estimated completion is 2018-02.
What interventions are being tested in trial NCT01515800?
The interventions under investigation include: Text message reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01515800?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.